Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
2.

Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study.

Warris A, Pana ZD, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, Groll AH, Roilides E, Andersen CT, Arendrup MC, Arsenijevic VA, Bianchini S, von Both U, Chmelnik M, Controzzi T, Emonts M, Esposito S, Ferreras-Antolin L, Henriet S, Iosifidis E, Irwin A, Kopsidas J, Lagrou K, Lyall H, Casteleiro AM, Mesini A, Olbrich P, Paulus S, Lausch KR, Soler-Palacin P, Spyridis N, Strenger V, Theodoraki M, Wolfs T; EUROCANDY Study Group**; **EUROCANDY study group:.

Pediatr Infect Dis J. 2020 Feb;39(2):114-120. doi: 10.1097/INF.0000000000002530.

PMID:
31725552
3.

Neonatal Antifungal Consumption Is Dominated by Prophylactic Use; Outcomes From The Pediatric Antifungal Stewardship: Optimizing Antifungal Prescription Study.

Ferreras-Antolín L, Irwin A, Atra A, Dermirjian A, Drysdale SB, Emonts M, McMaster P, Paulus S, Patel S, Kinsey S, Vergnano S, Whittaker E, Warris A.

Pediatr Infect Dis J. 2019 Dec;38(12):1219-1223. doi: 10.1097/INF.0000000000002463.

PMID:
31568253
4.

Management of Invasive Fungal Disease in Neonates and Children.

Ferreras-Antolín L, Sharland M, Warris A.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S2-S6. doi: 10.1097/INF.0000000000002317.

PMID:
31205236
5.

Introduction.

Curtis N, Finn A, Warris A, Pollard AJ, van Rossum A, Ramilo O.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S1. doi: 10.1097/INF.0000000000002316. No abstract available.

PMID:
31205235
6.

Raw genome sequence data for 13 isogenic Aspergillus fumigatus strains isolated over a 2 year period from a patient with chronic granulomatous disease.

Ballard E, Zoll J, Melchers WJG, Brown AJP, Warris A, Verweij PE.

Data Brief. 2019 May 23;25:104021. doi: 10.1016/j.dib.2019.104021. eCollection 2019 Aug.

7.

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.

Warris A, Lehrnbecher T, Roilides E, Castagnola E, Brüggemann RJM, Groll AH.

Clin Microbiol Infect. 2019 Sep;25(9):1096-1113. doi: 10.1016/j.cmi.2019.05.019. Epub 2019 May 31.

PMID:
31158517
8.

Recreation of in-host acquired single nucleotide polymorphisms by CRISPR-Cas9 reveals an uncharacterised gene playing a role in Aspergillus fumigatus azole resistance via a non-cyp51A mediated resistance mechanism.

Ballard E, Weber J, Melchers WJG, Tammireddy S, Whitfield PD, Brakhage AA, Brown AJP, Verweij PE, Warris A.

Fungal Genet Biol. 2019 Sep;130:98-106. doi: 10.1016/j.fgb.2019.05.005. Epub 2019 May 23.

9.

Cryptococcal meningitis after ART: Need for proper baseline evaluation in the era of 'Test & Treat'.

Akase IE, Olowoyo O, Oladele RO, Obiako RO, Warris A, Akanmu SA.

Med Mycol Case Rep. 2019 Apr 16;24:58-60. doi: 10.1016/j.mmcr.2019.04.003. eCollection 2019 Jun.

10.

Aspergillus colonization and antifungal immunity in cystic fibrosis patients.

Warris A, Bercusson A, Armstrong-James D.

Med Mycol. 2019 Apr 1;57(Supplement_2):S118-S126. doi: 10.1093/mmy/myy074. Review.

PMID:
30816976
11.

Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.

Lempers VJ, Meuwese E, Mavinkurve-Groothuis AM, Henriet S, van der Sluis IM, Hanff LM, Warris A, Koch BCP, Brüggemann RJ.

Med Mycol. 2019 Nov 1;57(8):937-943. doi: 10.1093/mmy/myz006.

PMID:
30759261
12.

Immunopathology of Aspergillus Infections in Children With Chronic Granulomatous Disease and Cystic Fibrosis.

Warris A.

Pediatr Infect Dis J. 2019 May;38(5):e96-e98. doi: 10.1097/INF.0000000000002265. No abstract available.

PMID:
30531311
13.

Memory in Fungal Pathogens Promotes Immune Evasion, Colonisation, and Infection.

Brown AJP, Gow NAR, Warris A, Brown GD.

Trends Microbiol. 2019 Mar;27(3):219-230. doi: 10.1016/j.tim.2018.11.001. Epub 2018 Nov 30. Review.

PMID:
30509563
14.

Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis.

Bercusson A, Colley T, Shah A, Warris A, Armstrong-James D.

Blood. 2018 Nov 1;132(18):1985-1988. doi: 10.1182/blood-2017-12-823393. Epub 2018 Jul 18. No abstract available.

15.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

16.

Strategic Research Funding: A Success Story for Medical Mycology.

Gow NAR, Amin T, McArdle K, Brown AJP, Brown GD, Warris A, The Wtsa-Mmfi Consortium.

Trends Microbiol. 2018 Oct;26(10):811-813. doi: 10.1016/j.tim.2018.05.014. Epub 2018 Jun 13.

17.

Microbiome characteristics of induced sputum compared to bronchial fluid and upper airway samples.

An SQ, Warris A, Turner S.

Pediatr Pulmonol. 2018 Jul;53(7):921-928. doi: 10.1002/ppul.24037. Epub 2018 May 4.

PMID:
29727521
18.

Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity.

Brunel SF, Willment JA, Brown GD, Devereux G, Warris A.

ERJ Open Res. 2018 Apr 9;4(2). pii: 00068-2017. doi: 10.1183/23120541.00068-2017. eCollection 2018 Apr.

19.

Candida auris, what do paediatricians need to know?

Warris A.

Arch Dis Child. 2018 Sep;103(9):891-894. doi: 10.1136/archdischild-2017-313960. Epub 2018 Mar 15. Review.

20.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

21.

Oxidative responses and fungal infection biology.

Warris A, Ballou ER.

Semin Cell Dev Biol. 2019 May;89:34-46. doi: 10.1016/j.semcdb.2018.03.004. Epub 2018 Mar 12. Review.

22.

In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis.

Ballard E, Melchers WJG, Zoll J, Brown AJP, Verweij PE, Warris A.

Fungal Genet Biol. 2018 Apr;113:1-13. doi: 10.1016/j.fgb.2018.02.003. Epub 2018 Feb 23.

23.

Special Issue: Host-Fungus Interactions.

Warris A.

J Fungi (Basel). 2018 Jan 2;4(1). pii: E7. doi: 10.3390/jof4010007.

24.

Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.

King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S12-S21. doi: 10.1093/jpids/pix053. Review.

25.

Epidemiology of Invasive Fungal Disease in Children.

Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S3-S11. doi: 10.1093/jpids/pix046. Review.

26.

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.

Bastiaans DET, Immohr LI, Zeinstra GG, Strik-Albers R, Pein-Hackelbusch M, van der Flier M, de Haan AFJ, Boelens JJ, Lankester AC, Burger DM, Warris A.

Br J Clin Pharmacol. 2017 Dec;83(12):2789-2797. doi: 10.1111/bcp.13396. Epub 2017 Sep 20.

27.

Progress in the Diagnosis of Invasive Fungal Disease in Children.

Warris A, Lehrnbecher T.

Curr Fungal Infect Rep. 2017;11(2):35-44. doi: 10.1007/s12281-017-0274-9. Epub 2017 May 2. Review.

28.

Recognition and diagnosis of invasive fungal infections in neonates.

Calley JL, Warris A.

J Infect. 2017 Jun;74 Suppl 1:S108-S113. doi: 10.1016/S0163-4453(17)30200-1. Review.

PMID:
28646949
29.

Preface.

Curtis N, Pollard AJ, Finn A, Ramilo O, Dobson S, Warris A, van Rossum A.

J Infect. 2017 Jun;74 Suppl 1:S1. doi: 10.1016/S0163-4453(17)30183-4. No abstract available.

PMID:
28646946
30.

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus.

Brunel SF, Bain JM, King J, Heung LJ, Kasahara S, Hohl TM, Warris A.

J Vis Exp. 2017 Apr 19;(122). doi: 10.3791/55444.

31.

Neutropenic acute acalculous cholecystitis (AAC) in a 12-year-old boy with T-acute lymphoblastic leukemia successfully managed with conservative treatment.

Naselli A, Bishop H, Walker S, Warris A.

Pediatr Hematol Oncol. 2017 Feb;34(1):24-28. doi: 10.1080/08880018.2016.1265034. Epub 2017 Jan 13.

PMID:
28085529
32.

Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus.

Seyedmousavi S, van der Lee HA, Verweij PE, Warris A.

Clin Microbiol Infect. 2017 Sep;23(9):679-681. doi: 10.1016/j.cmi.2016.12.021. Epub 2017 Jan 3. No abstract available.

33.

The role of the multidisciplinary team in antifungal stewardship.

Agrawal S, Barnes R, Brüggemann RJ, Rautemaa-Richardson R, Warris A.

J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii37-ii42.

PMID:
27880668
34.

Preface.

Curtis N, Pollard AJ, Finn A, Ramilo O, Dobson S, Warris A, van Rossum A.

J Infect. 2016 Jul 5;72 Suppl:1. doi: 10.1016/j.jinf.2016.06.003. No abstract available.

PMID:
27339109
35.

Sputum Induction in Children Is Feasible and Useful in a Bustling General Hospital Practice.

Bart IY, Mourits M, van Gent R, van Leuken MH, Hilbink M, Warris A, Wever PC, de Vries E.

Glob Pediatr Health. 2016 Mar 4;3:2333794X16636504. doi: 10.1177/2333794X16636504. eCollection 2016.

36.

Aspergillosis in Chronic Granulomatous Disease.

King J, Henriet SSV, Warris A.

J Fungi (Basel). 2016 May 26;2(2). pii: E15. doi: 10.3390/jof2020015. Review.

37.

Aspergillus infections in cystic fibrosis.

King J, Brunel SF, Warris A.

J Infect. 2016 Jul 5;72 Suppl:S50-5. doi: 10.1016/j.jinf.2016.04.022. Epub 2016 May 11. Review.

PMID:
27177733
38.

A new paediatric formulation of valaciclovir: development and bioequivalence assessment.

Bastiaans DE, Bartels-Wilmer CM, Colbers AP, Heijens CA, Velthoven-Graafland K, Smeets OS, Vink N, Harbers VE, Warris A, Burger DM.

Arch Dis Child. 2016 Oct;101(10):971-2. doi: 10.1136/archdischild-2015-310266. Epub 2016 May 9. No abstract available.

PMID:
27162003
39.

Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.

Henriet SS, van de Sande WW, Lee MJ, Simonetti E, Momany M, Verweij PE, Rijs AJ, Ferwerda G, Sheppard DC, de Jonge MI, Warris A.

J Interferon Cytokine Res. 2016 Aug;36(8):488-98. doi: 10.1089/jir.2015.0095. Epub 2016 May 4.

PMID:
27142572
40.

The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children.

Warris A; European Paediatric Mycology Network (EPMyN)*.

Curr Fungal Infect Rep. 2016;10:7-9. Epub 2016 Feb 26. Review.

41.

Bacterial Tracheitis and Septic Shock.

Tak R, Semmekrot B, Warris A, Yntema JB, Stelma F, Neeleman C.

Pediatr Infect Dis J. 2016 Feb;35(2):226-7. doi: 10.1097/INF.0000000000000981. No abstract available.

PMID:
26756267
42.

Prophylactic antibiotics should be used in children with repaired oesophageal atresia and tracheo-oesophageal fistula: The case against.

Warris A.

Paediatr Respir Rev. 2016 Mar;18:62-3. doi: 10.1016/j.prrv.2015.11.004. Epub 2015 Nov 14. Review. No abstract available.

PMID:
26654949
43.

ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia.

Bhatt JM, Bush A, van Gerven M, Nissenkorn A, Renke M, Yarlett L, Taylor M, Tonia T, Warris A, Zielen S, Zinna S, Merkus PJ; European Respiratory Society.

Eur Respir Rev. 2015 Dec;24(138):565-81. doi: 10.1183/16000617.0066-2015. Review.

44.

Ataxia telangiectasia: why should the ERS care?

Bhatt JM, Bush A, van Gerven M, Nissenkorn A, Renke M, Yarlett L, Taylor M, Tonia T, Warris A, Zielen S, Zinna S, Merkus PJ.

Eur Respir J. 2015 Dec;46(6):1557-60. doi: 10.1183/13993003.01456-2015. No abstract available.

45.

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, Kullberg BJ, Lagrou K, Maertens J, Meis JF, Newton P, Page I, Seyedmousavi S, Sheppard DC, Viscoli C, Warris A, Donnelly JP.

Drug Resist Updat. 2015 Jul-Aug;21-22:30-40. doi: 10.1016/j.drup.2015.08.001. Epub 2015 Aug 7.

46.

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.

Brand HK, Ahout IM, de Ridder D, van Diepen A, Li Y, Zaalberg M, Andeweg A, Roeleveld N, de Groot R, Warris A, Hermans PW, Ferwerda G, Staal FJ.

PLoS One. 2015 Jul 10;10(7):e0131927. doi: 10.1371/journal.pone.0131927. eCollection 2015.

47.

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.

48.

Impact of special patient populations on the pharmacokinetics of echinocandins.

Muilwijk EW, Lempers VJ, Burger DM, Warris A, Pickkers P, Aarnoutse RE, Brüggemann RJ.

Expert Rev Anti Infect Ther. 2015 Jun;13(6):799-815. doi: 10.1586/14787210.2015.1028366. Epub 2015 May 6. Review.

PMID:
25947367
49.

Azole-resistant aspergillosis.

Warris A.

J Infect. 2015 Jun;71 Suppl 1:S121-5. doi: 10.1016/j.jinf.2015.04.023. Epub 2015 Apr 25. Review.

PMID:
25917808
50.

Direct multiplexed whole genome sequencing of respiratory tract samples reveals full viral genomic information.

Zoll J, Rahamat-Langendoen J, Ahout I, de Jonge MI, Jans J, Huijnen MA, Ferwerda G, Warris A, Melchers WJ.

J Clin Virol. 2015 May;66:6-11. doi: 10.1016/j.jcv.2015.02.010. Epub 2015 Feb 18.

Supplemental Content

Loading ...
Support Center